Correction: Short-term L-arabinose administration alleviates MASLD by remodeling gut microbiota and activating hepatic ATF5-dependent mitochondrial unfolded protein response
Metabolism and Target Organ Damage · 14.08.2026 · 6 (3)
DOI: 10.20517/mtod.2026.172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolism and Target Organ Damage, online erschienen am 14.08.2026. Verfasst von Heng Zhang und 8 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, H., Chen, R., Zhang, W., Ning, J., Wang, Y., Li, Y., Zhao, M., Lin, D., & Wang, X. (2026). Correction: Short-term L-arabinose administration alleviates MASLD by remodeling gut microbiota and activating hepatic ATF5-dependent mitochondrial unfolded protein response. Metabolism and Target Organ Damage, 6(3). https://doi.org/10.20517/mtod.2026.172
Vancouver
Zhang H, Chen R, Zhang W, Ning J, Wang Y, Li Y, et al. Correction: Short-term L-arabinose administration alleviates MASLD by remodeling gut microbiota and activating hepatic ATF5-dependent mitochondrial unfolded protein response. Metabolism and Target Organ Damage. 2026;6(3). doi:10.20517/mtod.2026.172
BibTeX
@article{Zhang2026,
author = {Zhang, Heng and Chen, Ruhan and Zhang, Weiwei and Ning, Jie and Wang, Yao and Li, Yunxiao and Zhao, Meng and Lin, Dong and Wang, Xiaolei},
title = {Correction: Short-term L-arabinose administration alleviates MASLD by remodeling gut microbiota and activating hepatic ATF5-dependent mitochondrial unfolded protein response},
journal = {Metabolism and Target Organ Damage},
year = {2026},
volume = {6},
number = {3},
doi = {10.20517/mtod.2026.172}
}
EUVIMED